Skip to main content

Table 2 Baseline clinical characteristics and outcomes of patients categorized by TyG indexa

From: The triglyceride-glucose index: a novel predictor of stroke and all-cause mortality in liver transplantation recipients

 

All (N = 780)

T1 (N = 259)

T2 (N = 262)

T3 (N = 259)

P-value

Age (years)

49.00 (42.00–56.00)

46.00 (39.00–53.00)

50.00 (43.25-56.00)

50.00 (42.00–57.00)

< 0.001

Sex (male)

680 (87.18%)

228 (88.03%)

225 (85.88%)

227 (87.64%)

0.735

BMI

22.70 (21.00-24.42)

22.50 (20.80–24.20)

22.57 (20.83–24.37)

23.00 (21.15–24.70)

0.142

ASA

    

0.005

II

71 (9.10%)

13 (5.02%)

29 (11.07%)

29 (11.20%)

 

III

706 (90.51%)

246 (94.98%)

233 (88.93%)

227 (87.64%)

 

IV

3 (0.38%)

0 (0.00%)

0 (0.00%)

3 (1.16%)

 

Previous surgery

53 (6.79%)

21 (8.11%)

15 (5.73%)

17 (6.56%)

0.549

MELD

23.00 (22.00–34.00)

22.00 (22.00-34.50)

22.00 (22.00–30.00)

29.00 (22.00-36.50)

< 0.001

Renal insufficiency

207 (26.54%)

76 (29.34%)

62 (23.66%)

69 (26.64%)

0.340

Diabetes

109 (13.97%)

15 (5.79%)

40 (15.27%)

54 (20.85%)

< 0.001

Hypertension

67 (8.59%)

18 (6.95%)

27 (10.31%)

22 (8.49%)

0.392

HE

156 (20.00%)

54 (20.85%)

46 (17.56%)

56 (21.62%)

0.468

Hemodialysis

230 (29.49%)

80 (30.89%)

70 (26.72%)

80 (30.89%)

0.483

TYG index

8.23 (7.78–8.72)

7.62 (7.34–7.77)

8.23 (8.08–8.37)

8.96 (8.72–9.34)

< 0.001

Hemoglobin (g/L)

101.00 (83.00-122.00)

91.00 (78.00-108.00)

108.00 (87.00-124.00)

107.00 (85.00-132.03)

< 0.001

WBC (109/L)

5.39 (3.58–8.76)

4.83 (3.04–7.79)

4.96 (3.52–8.19)

6.52 (4.27–10.15)

< 0.001

Platelet (109/L)

72.52 (46.00-122.00)

61.00 (39.50–90.00)

74.00 (49.00-126.75)

92.00 (52.00-146.50)

< 0.001

Day-or-Night surgery

    

0.841

Day

504 (64.62%)

171 (66.02%)

168 (64.12%)

165 (63.71%)

 

Night

276 (35.38%)

88 (33.98%)

94 (35.88%)

94 (36.29%)

 

Surgery duration

521.00 (470.00-580.00)

530.00 (480.00-585.00)

515.00 (465.00-570.00)

520.00 (469.50–585.00)

0.145

Massive transfusion

231 (29.62%)

102 (39.38%)

61 (23.28%)

68 (26.25%)

< 0.001

Massive blood losing

37 (4.74%)

18 (6.95%)

7 (2.67%)

12 (4.63%)

0.071

Urinary oliguria

32 (4.10%)

9 (3.47%)

7 (2.67%)

16 (6.18%)

0.108

Cardiac arrest

16 (2.04%)

6 (2.32%)

7 (2.67%)

3 (1.16%)

0.445

Outcomes

     

Stroke

42 (5.38%)

8 (3.09%)

10 (3.82%)

24 (9.27%)

< 0.001

Hospital morality

43 (5.54%)

11 (4.31%)

11 (4.20%)

21 (8.11%)

0.027

1-year morality

103 (13.21%)

31 (11.97%)

28 (10.69%)

44 (16.99%)

0.028

3-year morality

123 (15.77%)

35 (13.51%)

36 (13.74%)

52 (20.08%)

0.020

  1. Note: Data were expressed as mean (standard deviation), median (interquartile range) or n (%). Bold data indicates significance at < 0.05
  2. aTyG index: T1 (< 7.92), T2 (7.92–8.53), T3 (> 8.53)
  3. Abbreviation: BMI, body mass index; ASA, American Society of Anesthesiologists; MELD, model for end-stage liver disease score; HE, hepatic encephalopathy; TyG, triglyceride-glucose index; WBC, white blood cell
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840